These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Lipid disorders in non-insulin dependent diabetes--principles of treatment]. Idzior-Waluś B Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531 [TBL] [Abstract][Full Text] [Related]
10. [Detection and treatment of of atherogenic hyperlipidemias]. Dairou F J Mal Vasc; 1988; 13(4):365-7. PubMed ID: 3199038 [TBL] [Abstract][Full Text] [Related]
11. Management of dyslipidemia. Akel MM; Salti I J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]
13. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia]. Yeshurun D; Hamood H; Morad N; Naschitz J Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206 [TBL] [Abstract][Full Text] [Related]
14. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634 [TBL] [Abstract][Full Text] [Related]
15. Hyperlipidemia in children with type 2 diabetes mellitus. Taha D J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():505-7. PubMed ID: 12017224 [TBL] [Abstract][Full Text] [Related]